Intraarterial Chemotherapy for Advanced Bladder Cancer

The results of prolonged intra-arterial chemotherapy in 61 patients with locally advanced bladder cancer (T3–T4) are discussed. Regional internal iliac artery infusion of chemotherapeutic agents was done daily for 5 or 7 days at a rate of 1 to 3 ml/h over an 18-20-h period. The total dosages of each course were 60–120 mg/m5adriamycin, 2.5–3.5 g/m25-fluorouracil (5-FU), 20–40 mg/m2methotrexate or 30–50 mg/m2cisplatin. At 3 to 4 weeks after the completion of infusional chemotherapy the results were evaluated, based on data from control cystoscopy and sonography. One patient (1.6 %) was free of tumor; an objective response of greater than 50 % reduction in tumor size occurred in 26 (42.7 %) patients; 34 (55.7 %) demonstrated objective responses of less than 50 %. No further increase in tumor size during the management was detected. Hematuria, dysuria and urine infection were controlled and pain was relieved. The use of cytostatics and prolonged iliac artery catheterization did not incur any serious complications.